Vector-Borne Disease Research
Are you looking for top-quality controls?
We’ve got you covered! ATCC houses a number of cultures and nucleic acids that support research on prevalent vector-borne diseases such as Zika, dengue, chikungunya, malaria, Lyme disease, and more!
- Pathogenic bacteria and protozoa
- In vivo and tissue culture-adapted viruses
- Genomic and synthetic nucleic acid preparations
- Host cell lines and reagents
- Custom solutions for expansion, titering, and banking
ATCC Genuine Cultures® and ATCC® Genuine Nucleics are high-quality, authenticated materials ideal for use as reference standards in the development and evaluation of novel vaccines, innovative therapeutics, and rapid diagnostic tools. Browse our vector-borne disease research solutions by clicking on the links provided below, or:
Download our white paper to discover ways to overcome key challenges during the development and validation of molecular-based assays!
the white paper
The WHO estimates that vector-borne diseases contribute to 17% of the estimated global burden of infectious diseases. To aid in vector-borne research, ATCC has compiled a collection of microbial species known to be transmitted by hematophagous arthropods. Search for strains by product category:
Zika virus reference materials - New!
The development and evaluation of rapid diagnostic methods is critical for the detection and effective treatment of vector-borne pathogens. ATCC offers an expanding collection of native and synthetic nucleic acids to support vector-borne research.
Find nucleic acids
Need an affordable solution to nucleic acid extractions, scaled-up production, or manufacturing? ATCC can help with customized services and solutions to meet your specific vector-borne research needs.